XNYS
AVNT
Market cap3.30bUSD
Jul 09, Last price
35.98USD
1D
0.70%
1Q
-5.84%
Jan 2017
12.30%
IPO
299.78%
Name
Avient Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Avient Corporation, established in 1885 and based in Avon Lake, Ohio, is a global enterprise specializing in advanced material solutions, custom formulation services, and sustainable products. The company, which operated as PolyOne Corporation until its rebranding in June 2020, serves markets across the United States, Canada, Mexico, Europe, South America, and Asia. Its operations are divided into three primary business units: 1. Color, Additives and Inks: This segment delivers bespoke colorants and additive concentrates, available in both solid and liquid forms for thermoplastic applications, alongside dispersions for thermosetting materials and various specialty inks. These products are integral to numerous industries, including medical and pharmaceutical devices, food packaging, personal care, cosmetics, transportation, building products, recreational goods, athletic apparel, construction, filtration, outdoor furniture, general healthcare, and wire and cable manufacturing. 2. Specialty Engineered Materials: This division provides sophisticated polymer formulations, expert services, and tailored solutions for professionals involved in the design, assembly, and processing of thermoplastic materials. It also supplies leading-edge long glass and carbon fiber technologies critical for both thermoset and thermoplastic composite applications. 3. Distribution: Through this segment, Avient facilitates the supply of an extensive range of approximately 4,000 distinct grades of engineering and commodity resins, primarily catering to custom injection molders and extruders. The company engages with its clientele via a multi-channel approach, utilizing a direct sales force, a network of distributors, and independent commissioned sales agents.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||